VB10.COV-2 vaccine

VB10.2129 encodes the receptor binding domain (RBD) derived from the the B1.351 (beta) SARS-CoV-2 variant; VB10.2210 A T cell-based vaccine candidate, encoding T-cell epitopes spanning multiple antigens across the SARS-CoV-2 genome

Also Known As:

VB10.2129; VB10.2129 COVID-19 vaccine; VB10.2129 vaccine; VB10.2210; VB10.2210 COVID-19 vaccine; VB10.2210 vaccine; VB10.COV-2; VB10.COV-2 COVID-19 vaccine

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Synthetic Vaccines: 1073
      - VB10.COV-2 vaccine
    - Viral Vaccines: 462
      - COVID-19 Vaccines: 7607
        VB10.COV-2 vaccine
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Recombinant Proteins: 2754
    - Synthetic Vaccines: 1073
      - VB10.COV-2 vaccine
Biological Factors: 2472
- Antigens: 143924
  - Synthetic Vaccines: 1073
    - VB10.COV-2 vaccine